Brief: Maia Biotechnology Announces Open Market Purchases By CEO And Directors
01/12/2025 14:18
Dec 1 (Reuters) - Maia Biotechnology Inc MAIA.A: MAIA BIOTECHNOLOGY ANNOUNCES OPEN MARKET PURCHASES BY CEO AND DIRECTORS MAIA BIOTECHNOLOGY INC - CEO VLAD VITOC PURCHASES 94,300 SHARES AT $1.08 EACH MAIA BIOTECHNOLOGY INC - BOARD MEMBERS PURCHASE 88,145 SHARES AT $1.04 EACH Source text: ID:nGNX6tDmpV Further company coverage: MAIA.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Maia Biotechnology
See all newsBrief: Maia Biotechnology Says Ateganosine Plus Cemiplimab Outperforms Standard Chemotherapy Dcr In 3l Nsclc
Brief: Maia Biotechnology - To Terminate At The Market Offering Agreement Effective May 23, 2026 - SEC Filing
Brief: Maia Biotechnology Reports Overall Survival Exceeding Two Years For Eight Patients In Ongoing Phase 2 Clinical Trial In Non-Small Cell Lung Cancer
Brief: Maia Biotechnology Inc Enters Underwriting Agreement With Konik Capital Partners - SEC Filing
MAIA Biotechnology plunges after $30 million share sale